These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3371265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms.
    Clapp C.
    Endocrinology; 1987 Dec; 121(6):2055-64. PubMed ID: 3315634
    [Abstract] [Full Text] [Related]

  • 3. Binding studies with intact rat prolactin and a 16K fragment of the hormone.
    Clapp C, Sears PS, Nicoll CS.
    Endocrinology; 1989 Aug; 125(2):1054-9. PubMed ID: 2752964
    [Abstract] [Full Text] [Related]

  • 4. Processing of rat prolactin by rat tissue explants and serum in vitro.
    Baldocchi RA, Tan L, Nicoll CS.
    Endocrinology; 1992 Mar; 130(3):1653-9. PubMed ID: 1537313
    [Abstract] [Full Text] [Related]

  • 5. Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin.
    Khurana S, Liby K, Buckley AR, Ben-Jonathan N.
    Endocrinology; 1999 Sep; 140(9):4127-32. PubMed ID: 10465285
    [Abstract] [Full Text] [Related]

  • 6. Cleaved prolactin and its 16K fragment are generated by an acid protease.
    Casabiell X, Robertson MC, Friesen HG, Casanueva FF.
    Endocrinology; 1989 Oct; 125(4):1967-72. PubMed ID: 2676475
    [Abstract] [Full Text] [Related]

  • 7. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
    Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI.
    Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
    [Abstract] [Full Text] [Related]

  • 8. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells.
    Clapp C, Weiner RI.
    Endocrinology; 1992 Mar; 130(3):1380-6. PubMed ID: 1311239
    [Abstract] [Full Text] [Related]

  • 9. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells.
    Ferrara N, Clapp C, Weiner R.
    Endocrinology; 1991 Aug; 129(2):896-900. PubMed ID: 1855480
    [Abstract] [Full Text] [Related]

  • 10. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.
    Clapp C, Torner L, Gutiérrez-Ospina G, Alcántara E, López-Gómez FJ, Nagano M, Kelly PA, Mejía S, Morales MA, Martínez de la Escalera G.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10384-8. PubMed ID: 7937959
    [Abstract] [Full Text] [Related]

  • 11. Cleavage of prolactin by its target organs and the possible significance of this process.
    Nicoll CS.
    J Mammary Gland Biol Neoplasia; 1997 Jan 25; 2(1):81-9. PubMed ID: 10887522
    [Abstract] [Full Text] [Related]

  • 12. Preparation of the extracellular domain of the rabbit prolactin receptor expressed in Escherichia coli and its interaction with lactogenic hormones.
    Bignon C, Sakal E, Belair L, Chapnik-Cohen N, Djiane J, Gertler A.
    J Biol Chem; 1994 Feb 04; 269(5):3318-24. PubMed ID: 8106371
    [Abstract] [Full Text] [Related]

  • 13. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance.
    Piwnica D, Touraine P, Struman I, Tabruyn S, Bolbach G, Clapp C, Martial JA, Kelly PA, Goffin V.
    Mol Endocrinol; 2004 Oct 04; 18(10):2522-42. PubMed ID: 15192082
    [Abstract] [Full Text] [Related]

  • 14. Electrophoretically separable forms of rat prolactin with different bioassay and radioimmunoassay activities.
    Asawaroengchai H, Russell SM, Nicoll CS.
    Endocrinology; 1978 Feb 04; 102(2):407-14. PubMed ID: 743965
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of purified and secreted rat prolactin in vitro.
    Asawaroengchai H.
    Horm Res; 1978 Feb 04; 9(3):151-60. PubMed ID: 640579
    [Abstract] [Full Text] [Related]

  • 16. A cleaved form of prolactin in the mouse pituitary gland: identification and comparison of in vitro synthesis and release in strains with high and low incidences of mammary tumors.
    Sinha YN, Gilligan TA.
    Endocrinology; 1984 Jun 04; 114(6):2046-53. PubMed ID: 6723574
    [Abstract] [Full Text] [Related]

  • 17. Glycosylation selectively alters the biological activity of prolactin.
    Markoff E, Sigel MB, Lacour N, Seavey BK, Friesen HG, Lewis UJ.
    Endocrinology; 1988 Sep 04; 123(3):1303-6. PubMed ID: 3402386
    [Abstract] [Full Text] [Related]

  • 18. A novel "cleaved prolactin" in the rat pituitary: Part II. In vivo mammary mitogenic activity of its N-terminal 16K moiety.
    Mittra I.
    Biochem Biophys Res Commun; 1980 Aug 29; 95(4):1760-7. PubMed ID: 7417343
    [No Abstract] [Full Text] [Related]

  • 19. Cleavage of rat prolactin occurs within rat mammary tissue, and the cleaved form is present in serum but not in milk.
    Baldocchi RA, Chou YC, Nicoll CS.
    Proc Soc Exp Biol Med; 1994 Sep 29; 206(4):416-20. PubMed ID: 8073051
    [Abstract] [Full Text] [Related]

  • 20. Molecular heterogeneity of prolactin in lactating rats and their pups: biological and immunological activities in pituitary gland, serum and milk.
    Kacsóh B, Tóth BE, Avery LM, Yamamuro Y, Grosvenor CE.
    Endocr Regul; 1991 Jun 29; 25(1-2):98-110. PubMed ID: 1958841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.